13F Portfolios

SurgoCap Partners LP 13F: Quarter-over-Quarter Portfolio Changes

SurgoCap Partners LP reported a disclosed portfolio value of approximately $3.1 billion in its latest SEC Form 13F-HR filing for Q2 2026, up 3.3% quarter on quarter. Over the quarter, the fund initiated 3 new positions, bought more shares in 4 holdings, trimmed 6 holdings, and exited 4 positions.

SurgoCap Partners LP's top buy was a new stake in Intel CORP (INTC) , equal to 8.3% of the disclosed portfolio. Its top sell was Nvidia Corporation (NVDA) . The fund exited the position completely after it had accounted for 5.9% of the previous portfolio.

New PositionsQ2 2026

Securities disclosed for the first time in Q2 2026 that were not present in the prior 13F-HR filing.

SurgoCap Partners LP new positions in Q2 2026, representing first-time disclosed long equity stakes
CompanyTickerInitial Portfolio WeightHistory
INTEL CORPINTC8.3%History →
ARGAN INCAGX3.9%History →
DPC HOLDINGS PLCDPC1.0%Holders →

Top BuysQ2 2026

The fund's top buys among existing positions in Q2 2026. Ranked by portfolio-weight impact, with the percentage of additional shares shown separately.

SurgoCap Partners LP top buys in existing positions in Q2 2026
CompanyTickerPortfolio Weight ChangeMore SharesHistory
VISA INC-CLASS A SHRSV+3.3%+95.7%History →
MEDLINE INCMDLN+0.5%+23.2%History →
MCKESSON CORPMCK+-0.9%+8.1%History →
LPL FINL HLDGS INCLPLA+-0.6%+4.2%History →

Top SellsQ2 2026

The fund's top sells among positions it retained in Q2 2026. Ranked by portfolio-weight impact. Full exits are listed separately.

SurgoCap Partners LP top sells in existing positions in Q2 2026
CompanyTickerPortfolio Weight ChangeShares SoldHistory
CARPENTER TECHNOLOGY CORPCRS-2.1%42.6%History →
ALPHABET INCGOOG-3.2%35.1%History →
INTUITIVE SURGICAL INCISRG-1.8%22.8%Holders →
NU HLDGS LTDNU-1.3%18.9%Holders →
TAIWAN SEMICONDUCTOR MANUFACTSM1.5%18.1%History →
CORNING INCGLW2.7%7.1%History →

Full ExitsQ2 2026

Positions present in the prior 13F-HR filing that no longer appear in Q2 2026.

SurgoCap Partners LP full exits in Q2 2026
CompanyTickerLast-Reported Portfolio Weight
NVIDIA CORPORATIONNVDA5.9%
NIQ GLOBAL INTELLIGENCE PLCNIQ2.2%
SHOPIFY INCSHOP2.0%
FIGMA INCFIG1.3%
Latest

Net Portfolio Value ChangeQ2 2026

  • $3.0B
    Prior quarter
  • $3.1B
    Current quarter
  • +$0.1B
    Net delta
  • +3.3%
    % change

Methodology & FAQ

How SurgoCap Partners LP Quarterly Changes Are Computed

All deltas are sourced from sequential SEC Form 13F-HR filings for SurgoCap Partners LP: each row joins the most recent filing against the immediately preceding quarterly filing for the same fund. Share-count changes reflect reported trading activity, while portfolio weights can also move because of market price changes. Portfolio weights are normalized to exclude listed options for comparability. A complete description, including how confidential treatment filings are handled, is documented in the Methodology.

What stocks did SurgoCap Partners LP buy in Q2 2026?

In Q2 2026, SurgoCap Partners LP initiated 3 new positions (INTEL CORP (INTC), ARGAN INC (AGX), DPC HOLDINGS PLC (DPC)); bought more shares of VISA INC-CLASS A SHRS (V), MEDLINE INC (MDLN), MCKESSON CORP (MCK), LPL FINL HLDGS INC (LPLA).

What stocks did SurgoCap Partners LP sell in Q2 2026?

In Q2 2026, SurgoCap Partners LP fully sold 4 positions (NVIDIA CORPORATION (NVDA), NIQ GLOBAL INTELLIGENCE PLC (NIQ), SHOPIFY INC (SHOP), FIGMA INC (FIG)); reduced holdings in CARPENTER TECHNOLOGY CORP (CRS), ALPHABET INC (GOOG), INTUITIVE SURGICAL INC (ISRG), NU HLDGS LTD (NU), TAIWAN SEMICONDUCTOR MANUFAC (TSM) (the largest 5 of 6 reductions).

Which positions did SurgoCap Partners LP initiate in Q2 2026?

SurgoCap Partners LP established 3 new positions in Q2 2026: INTEL CORP (INTC, 8.3%), ARGAN INC (AGX, 3.9%), DPC HOLDINGS PLC (DPC, 1.0%).

Which existing positions saw the largest allocation increases for SurgoCap Partners LP in Q2 2026?

Of 4 existing positions with share-count increases in Q2 2026, the largest were: VISA INC-CLASS A SHRS (V, +3.3% weight, +95.7% shares), MEDLINE INC (MDLN, +0.5% weight, +23.2% shares), MCKESSON CORP (MCK, +-0.9% weight, +8.1% shares), LPL FINL HLDGS INC (LPLA, +-0.6% weight, +4.2% shares).

Which positions did SurgoCap Partners LP fully exit in Q2 2026?

SurgoCap Partners LP fully exited 4 positions in Q2 2026: NVIDIA CORPORATION (NVDA, last-reported weight 5.9%), NIQ GLOBAL INTELLIGENCE PLC (NIQ, last-reported weight 2.2%), SHOPIFY INC (SHOP, last-reported weight 2.0%), FIGMA INC (FIG, last-reported weight 1.3%).

Which existing positions saw the largest allocation reductions for SurgoCap Partners LP in Q2 2026?

Of 6 existing positions with share-count reductions in Q2 2026, the largest were: CARPENTER TECHNOLOGY CORP (CRS, -2.1% weight, -42.6% shares), ALPHABET INC (GOOG, -3.2% weight, -35.1% shares), INTUITIVE SURGICAL INC (ISRG, -1.8% weight, -22.8% shares), NU HLDGS LTD (NU, -1.3% weight, -18.9% shares), TAIWAN SEMICONDUCTOR MANUFAC (TSM, 1.5% weight, -18.1% shares), CORNING INC (GLW, 2.7% weight, -7.1% shares).

Do quarter-over-quarter 13F allocation changes constitute explicit trading signals?

No. Quarter-over-quarter changes reflect a combination of active trading and market price movement. A weight increase can result from price appreciation alone, without the manager adding shares. Share-count delta is the cleaner indicator of explicit trading activity. All deltas on this page are sourced from sequential SEC Form 13F-HR filings.